Last reviewed · How we verify
NCT05419687: VIA-H
Violence Against Health Care Workers in Fragile Settings
NA trial testing Training in de-escalating violence in Workplace Violence in 798 participants. Completed in 31 October 2024.
31 October 2024
Quick facts
| Lead sponsor | Swiss Tropical & Public Health Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | health services research |
| Enrollment | 798 |
| Start date | 1 November 2022 |
| Primary completion | 31 October 2024 |
| Estimated completion | 31 October 2024 |
| Sites | 2 locations across Democratic Republic of the Congo, Iraq |
Drugs / interventions tested
- Training in de-escalating violence
- Code of conduct delivered via a warning board
Conditions studied
- Workplace Violence — all drugs for Workplace Violence →
Sponsor
Swiss Tropical & Public Health Institute
Who can join
18 and older, any sex, with Workplace Violence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The general objective of the project is to assess whether a violence de-escalating training for health professionals and of a publicly displayed Code of Conduct (a set of rules developed through a citizen science and co-design approach) for both health professionals and clients at the level of the health facility, can reduce the incidence and severity of episodes of violence, and to identify the most cost-effective way to implement these interventions in rural Democratic Republic of Congo (DRC) and in the mega city of Baghdad, Iraq.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Understanding context of violence against healthcare through citizen science and evaluating the effectiveness of a co-designed code of conduct and of a tailored de-escalation of violence training in Eastern Democratic Republic of Congo and Iraq: a study protocol for a stepped wed
Ferrari G, Lwamushi SM, Balaluka GB, Lafta RK, et al · · 2023 · PMID 38110997 · DOI 10.1186/s13063-023-07839-3 -
Understanding context of violence against healthcare through citizen science and evaluating the effectiveness of a co-designed code of conduct and of a tailored de-escalation of violence training in Eastern Democratic Republic of Congo and Iraq: a study protocol for a stepped wed
Ferrari G, Lwamushi SM, Balaluka GB, Lafta RK, et al · · 2023 · DOI 10.21203/rs.3.rs-2896841/v1
Verify or expand the search:
- PubMed search for NCT05419687
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Swiss Tropical & Public Health Institute trials
Trials by the same sponsor.
- NCT06606860 — Safety, Tolerability and PK of Single and Multiple Doses of Oxantel Pamoate Tablets · Phase 1 · completed
- NCT06373835 — Efficacy and Safety of Emodepside in Adults Infected With Strongyloidiasis Stercoralis · Phase 2 · completed
- NCT06304831 — Use of Facility Ratings to Improve Satisfaction With Heath Care for Children · NA · completed
- NCT05644067 — Assessment of the Malaria Vaccine Candidate SumayaVac-1 in Healthy Adults Aged 18-45 Years Living in a Malaria Endemic C · Phase 1 · completed
- NCT06648603 — Citizen Action for Sustainable Dengue Control in Sub-Saharan Africa · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05419687 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Swiss Tropical & Public Health Institute
- Last refreshed: 22 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05419687.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing